Literature DB >> 26740238

Demographic characteristics and distribution of lysosomal storage disorder subtypes in Eastern China.

Xueru Chen1, Wenjuan Qiu1, Jun Ye1, Lianshu Han1, Xuefan Gu1, Huiwen Zhang1.   

Abstract

Lysosomal storage disorders (LSDs) are a group of >50 different types of inherited metabolic disorders that result from defects in the lysosome. The aim of this study was to investigate the distribution and demographic characteristics of the different subtypes of LSDs in Eastern China. From 2006 to 2012, 376 out of 1331 clinically suspected patients were diagnosed with 17 different subtypes of LSDs at our hospital. Mucopolysaccharidoses (MPS) were the most common group of LSDs (50.5%), followed by sphingolipidoses (25.4%) and Pompe disease (19.8%). Mucolipidosis type II/III accounted for the remaining 4% of diagnosed LSDs. MPS II was the most common form of MPS, comprising 47.4% of all MPS cases diagnosed, followed by MPS IVA (26.8%) and MPS I (16.3%). Gaucher disease and Niemann-Pick disease type A/B were the two most common forms of sphingolipidoses. There was a large variation in the time between disease onset and eventual diagnosis, from 0.3 years in infantile-onset Pompe disease to 30 years in Fabry disease, highlighting timely and accurate diagnosis of LSDs as the main challenge in China.

Entities:  

Mesh:

Year:  2016        PMID: 26740238     DOI: 10.1038/jhg.2015.155

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  27 in total

1.  Mucopolysaccharidosis type II: identification of 30 novel mutations among Latin American patients.

Authors:  A C Brusius-Facchin; I V D Schwartz; C Zimmer; M G Ribeiro; A X Acosta; D Horovitz; I L Monlleó; M I B Fontes; A Fett-Conte; R P Oliveira Sobrinho; A R Duarte; R Boy; P Mabe; M Ascurra; M de Michelena; K L Tylee; G T N Besley; M C V Garreton; R Giugliani; S Leistner-Segal
Journal:  Mol Genet Metab       Date:  2013-09-01       Impact factor: 4.797

2.  [Analysis of GALNS gene mutation in thirty-eight Chinese patients with mucopolysaccharidosis type IVA].

Authors:  Jun Ye; Hong-lin Lei; Hui-wen Zhang; Wen-juan Qiu; Lian-shu Han; Yu Wang; Xiao-yan Li; Xue-fan Gu
Journal:  Zhonghua Er Ke Za Zhi       Date:  2013-06

3.  [Enzymatic diagnosis and clinical characteristics of 52 children with mucopolysaccharidosis].

Authors:  Yong-Lan Huang; She-Yong Li; Xiao-Yuan Zhao; Li-Ping Fan; Wen-Chun Lin; Zhi-Hong Zhou; Jing Cheng; Li Liu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2012-07

4.  [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].

Authors:  Yan-long Duan; Yong-hong Zhang; Yan Zang; Hui-ping Shi; Wei-min Zhang; Ya-mei Hu
Journal:  Zhonghua Er Ke Za Zhi       Date:  2006-09

5.  Plasma hyaluronidase activity in mucolipidoses II and III: marked differences from other lysosomal enzymes.

Authors:  M R Natowicz; Y Wang
Journal:  Am J Med Genet       Date:  1996-10-28

6.  The frequency of lysosomal storage diseases in The Netherlands.

Authors:  B J Poorthuis; R A Wevers; W J Kleijer; J E Groener; J G de Jong; S van Weely; K E Niezen-Koning; O P van Diggelen
Journal:  Hum Genet       Date:  1999 Jul-Aug       Impact factor: 4.132

7.  Mutation analysis in the iduronate-2-sulphatase gene in 43 Japanese patients with mucopolysaccharidosis type II (Hunter disease).

Authors:  K Isogai; K Sukegawa; S Tomatsu; T Fukao; X Q Song; Y Yamada; S Fukuda; T Orii; N Kondo
Journal:  J Inherit Metab Dis       Date:  1998-02       Impact factor: 4.982

8.  Prevalence of lysosomal storage diseases in Portugal.

Authors:  Rui Pinto; Carla Caseiro; Manuela Lemos; Lurdes Lopes; Augusta Fontes; Helena Ribeiro; Eugénia Pinto; Elisabete Silva; Sónia Rocha; Ana Marcão; Isaura Ribeiro; Lúcia Lacerda; Gil Ribeiro; Olga Amaral; M C Sá Miranda
Journal:  Eur J Hum Genet       Date:  2004-02       Impact factor: 4.246

9.  Detection of Hunter syndrome (mucopolysaccharidosis type II) in Taiwanese: biochemical and linkage studies of the iduronate-2-sulfatase gene defects in MPS II patients and carriers.

Authors:  Shuan-Pei Lin; Jui-Hung Chang; Guey-Jen Lee-Chen; Dar-Shong Lin; Hsiang-Yu Lin; Chih-Kuang Chuang
Journal:  Clin Chim Acta       Date:  2006-02-09       Impact factor: 3.786

10.  [Enzymatic diagnosis of 47 cases with mucopolysaccharidosis].

Authors:  Hui-Wen Zhang; Yu Wang; Jun Ye; Wen-Juan Qiu; Lian-Shu Han; Xiao-Lan Gao; Xue-Fan Gu
Journal:  Zhonghua Er Ke Za Zhi       Date:  2009-04
View more
  11 in total

Review 1.  Impact of lysosome status on extracellular vesicle content and release.

Authors:  Erez Eitan; Caitlin Suire; Shi Zhang; Mark P Mattson
Journal:  Ageing Res Rev       Date:  2016-05-26       Impact factor: 10.895

2.  Epidemiology of mucopolysaccharidoses.

Authors:  Shaukat A Khan; Hira Peracha; Diana Ballhausen; Alfred Wiesbauer; Marianne Rohrbach; Matthias Gautschi; Robert W Mason; Roberto Giugliani; Yasuyuki Suzuki; Kenji E Orii; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2017-05-26       Impact factor: 4.797

3.  Mucopolysaccharidoses diagnosis in the era of enzyme replacement therapy in Egypt.

Authors:  Ekram Fateen; Zeinab Y Abdallah; Walaa S Nazim; Mona Ibrahim; Amira Radwan
Journal:  Heliyon       Date:  2021-08-19

4.  A pilot screening of high-risk Gaucher disease children using dried blood spot methods in Shandong province of China.

Authors:  Ke Lei; Yanxia Zhao; Lirong Sun; Hui Liang; Ronghua Luo; Xiaojing Sun; Yanling Tao; Lijun Chen; Lingling Zhang; Aimin Li; Fu Li; Hongfang Ding
Journal:  Orphanet J Rare Dis       Date:  2018-04-06       Impact factor: 4.123

5.  Selective screening for detection of mucopolysaccharidoses in Malaysia; A two-year study (2014-2016).

Authors:  Affandi Omar; Julaina A Jalil; Norashareena M Shakrin; Lock H Ngu; Zabedah M Yunus
Journal:  Mol Genet Metab Rep       Date:  2019-05-10

6.  Updated birth prevalence and relative frequency of mucopolysaccharidoses across Brazilian regions.

Authors:  Juliana Alves Josahkian; Franciele Barbosa Trapp; Maira Graeff Burin; Kristiane Michelin-Tirelli; Ana Paula Pereira Scholz de Magalhães; Fernanda Medeiros Sebastião; Fernanda Bender; Jurema Fátima De Mari; Ana Carolina Brusius-Facchin; Sandra Leistner-Segal; Diana Rojas Málaga; Roberto Giugliani
Journal:  Genet Mol Biol       Date:  2021-01-27       Impact factor: 1.771

Review 7.  Epidemiology of Mucopolysaccharidoses Update.

Authors:  Betul Çelik; Saori C Tomatsu; Shunji Tomatsu; Shaukat A Khan
Journal:  Diagnostics (Basel)       Date:  2021-02-10

8.  Prevalence of lysosomal storage disorders in Australia from 2009 to 2020.

Authors:  Sharon J Chin; Maria Fuller
Journal:  Lancet Reg Health West Pac       Date:  2021-12-12

Review 9.  Diagnosis of Mucopolysaccharidoses.

Authors:  Francyne Kubaski; Fabiano de Oliveira Poswar; Kristiane Michelin-Tirelli; Maira Graeff Burin; Diana Rojas-Málaga; Ana Carolina Brusius-Facchin; Sandra Leistner-Segal; Roberto Giugliani
Journal:  Diagnostics (Basel)       Date:  2020-03-22

10.  Presentation and Treatments for Mucopolysaccharidosis Type II (MPS II; Hunter Syndrome).

Authors:  Molly Stapleton; Francyne Kubaski; Robert W Mason; Hiromasa Yabe; Yasuyuki Suzuki; Kenji E Orii; Tadao Orii; Shunji Tomatsu
Journal:  Expert Opin Orphan Drugs       Date:  2017-03-08       Impact factor: 0.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.